SCHEDULE 13G/AAccepted May 15, 4:30 PM ET
Enliven Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
4:30 PM
May 15, 2026
Filed
May 15, 2026
Documents
2
Size
15.4 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.